PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

BASEL, Switzerland, January 26, 2017 - Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof ® IQ PanOptix ® Toric presbyopia- and astigmatism-correcting ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL) has surpassed more than one million ...

Please provide your email address to receive an email when new articles are posted on . A prospective comparative case series of 50 patients implanted bilaterally ...

It’s the first FDA approved trifocal lens implant to correct vision in three ways. It’s called PanOptix. Ophthalmologist Dr. Jeffery Horn of Vision for Life in Nashville was part of the clinical study ...

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...